Sechrist Industries And Dartmouth's Geisel School Of Medicine Work Together To Bring Hyperbaric Oxygen Therapy To Tanzania
ANAHEIM, Calif., June 26, 2018 -- (Healthcare Sales &Marketing Network) -- Sechrist Industries, Inc. has partnered with Jay Buckey, MD, Professor of Medicine at Dartmouth College's Geisel School of Medicine, to bring Hyperbaric Oxygen Therapy (HBOT) to T... Devices Sechrist Industries, hyperbaric oxygen, hyperbaric therapy, hyperbaric chamber
Huidi Tchero, Christian Herlin, Farid Bekara, Sergiu Fluieraru, Luc TeotIndian Journal of Dermatology, Venereology, and Leprology 2019 85(3):248-257 Hidradenitis suppurativa is a chronic inflammatory condition that affects skin regions bearing apocrine glands. Although hidradenitis suppurativa is difficult to treat and cure, the currently available treatments are directed toward managing the lesions and associated symptoms. This review presents an evidence-based outline of the available treatment options. We searched four electronic databases and extracted data from retrieved studies for qualitative or quantitative analys...
Condition: Breast Cancer Interventions: Procedure: Hyperbaric Oxygen Therapy; Drug: Trental Pill; Dietary Supplement: Vitamin E Sponsor: Legacy Health System Not yet recruiting
Publication date: May 2019Source: Journal of Vascular Surgery: Venous and Lymphatic Disorders, Volume 7, Issue 3Author(s): K.R. Thistlethwaite, K.J. Finlayson, P.D. Cooper, B. Brown, M.H. Bennett, G. Kay
AbstractBackgroundThe aim of this paper is to determine which therapy gives best results regarding process of healing of diabetic foot ulcers among three proposed: only negative pressure wound therapy, only hyperbaric oxygen therapy, and both when used in conjunction.MethodsThis bicentric prospective study included 60 patients, and they were, consecutively, assigned to one of three groups. The first group consisted of 20 patients who were treated only by hyperbaric oxygen therapy, second group consisted of 20 patients treated with combined hyperbaric oxygen and negative pressure wound therapy, and third group consisted of ...
CONCLUSIONS: BM-MNC induced angiogenesis in the ischemic limbs and was considered an effective resource for cell therapy. The preliminary data of this study showed that the combination of cell therapy with apelin-13 and HBOT improved the efficacy of angiogenesis. PMID: 30964192 [PubMed - in process]
Abstract AIMS: Hyperbaric oxygen therapy (HBOT) has been widely used as postinjury treatment; however, we investigate its ability to mitigate potential damage as a preconditioning option. Here, we tested the hypothesis that HBOT preconditioning mitigates cell death in primary rat neuronal cells (PRNCs) through the transfer of mitochondria from astrocytes. METHODS: Primary rat neuronal cells were subjected to a 90-minute HBOT treatment at 2.5 absolute atmospheres prior to either tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) injury to simulate the inflammation-plagued secondary cell death ...
CONCLUSION: The positive role of hyperbaric xenon in the preservation of erythrocytes is attributed to the equilibrium extraction and displacement of O2 and CO2 by xenon. The effect is presumably due to a lowering of oxygen concentration and a decrease in the production of reactive oxygen species. PMID: 30963157 [PubMed - in process]
Osteoradionecrosis (ORN) is an infrequent but serious complication of radiotherapy, especially in the head and neck region. It is a slowly progressive condition, with management in the early stages focused on symptom control, and surgery usually reserved for advanced ORN. However, established ORN is difficult to treat. The role of hyperbaric oxygen therapy has recently been contested. The use of pentoxifylline in the management of ORN was first described by Delanian in 2004, but its benefits have not been replicated in other studies.